Prosecution Insights
Last updated: November 13, 2026

Bovonex Inc.

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Bovonex Inc. currently has 1 pending office action. This action is assigned to WILLIAMS, CATHERINE SERKE, who is the 1 examiner currently active on the company's pending files. The prosecution is localized in 1 distinct art unit, indicating a focused technical review despite the absence of a broad technology area classification. For a practitioner, the presence of 1 pending office action under 1 examiner means the immediate strategy is singular. There is no need to coordinate across different art units or examiner styles.

WILLIAMS, CATHERINE SERKE, as the busiest examiner with 1 pending action, handles the entirety of the company's current USPTO workload. This profile indicates a highly concentrated prosecution effort where the practitioner can focus on a 1 set of examiner preferences. The administrative overhead is minimal given the low volume of pending matters. Success in this 1 action is critical as it represents the whole of the company's current pending activity at the USPTO. Practitioners should prioritize direct communication with WILLIAMS, CATHERINE SERKE to advance this matter within the 1 distinct art unit.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILLIAMS, CATHERINE SERKE 1 62.5% +29.7%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18840935 METHOD AND APPARATUS FOR MEDICAL INJECTION WILLIAMS, CATHERINE SERKE —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18840935 METHOD AND APPARATUS FOR MEDICAL INJECTION WILLIAMS, CATHERINE SERKE —

Top Art Units

Art UnitApps
3993 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18840935 METHOD AND APPARATUS FOR MEDICAL INJECTION WILLIAMS, CATHERINE SERKE 3993 §102§103 Non-Final OA — Pending Aug 23, 2024

Managing Bovonex Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Bovonex Inc. have?

Bovonex Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Bovonex Inc. applications?

Catherine Serke Williams has the most, with 1 of Bovonex Inc.'s pending office actions.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month